Related Experiment Video
Updated: Jul 18, 2026
Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer
Published on: March 24, 2013
Dual-Signal Chemical Exchange Saturation Transfer (Dusi-CEST): An Efficient Strategy for Visualizing Drug Delivery
Chenlu Yuan1, Qianni Guo1,2,3, Qingbin Zeng1,2
1Key Laboratory of Magnetic Resonance in Biological Systems, State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, National Center for Magnetic Resonance in Wuhan, Wuhan Institute of Physics and Mathematics, Innovation Academy for Precision Measurement Science and Technology, Chinese Academy of Sciences-Wuhan National Laboratory for Optoelectronics, Huazhong University of Science and Technology, Wuhan 430071, China.
We developed a dual-signal chemical exchange saturation transfer (Dusi-CEST) strategy for tracking drug delivery in cells. This method uses a nanoparticle probe to accurately detect drug loading and release, improving diagnostic reliability.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Chemical Biology
Background:
- Chemical Exchange Saturation Transfer (CEST) is a sensitive MRI technique.
- Existing CEST methods face challenges in complex biological environments.
- Developing targeted probes for intracellular drug delivery and monitoring is crucial.
Purpose of the Study:
- To introduce a novel dual-signal chemical exchange saturation transfer (Dusi-CEST) strategy.
- To demonstrate the application of Dusi-CEST for monitoring drug delivery in living cells.
- To enhance the accuracy and sensitivity of detection in complex biological systems.
Main Methods:
- Utilized a cucurbit[6]uril (CB[6]) nanoparticle probe with dual hydrophobic cavities.
- Employed hyperpolarized 129Xe Nuclear Magnetic Resonance (NMR) spectroscopy.
- Monitored changes in 129Xe NMR signals at 100 and 200 ppm upon drug loading and release.
Main Results:
- The CB[6] probe exhibited two distinct 129Xe NMR signals corresponding to xenon in different cavities.
- Drug loading (e.g., paclitaxel) and release caused significant, measurable changes in these signals.
- A metric was derived from signal changes to assess drug delivery efficacy.
Conclusions:
- Dusi-CEST provides a robust platform for real-time monitoring of intracellular drug delivery.
- The dual-signal approach enhances reliability by reducing false positives/negatives in biological samples.
- This strategy offers improved accuracy and sensitivity for single-shot detection in complex environments.
